期刊文献+

13-顺式维甲酸体外诱导3种神经母细胞瘤细胞株分化研究 被引量:3

Study on 13 - cis retinoic acid inducing differentiation of three types of human neuroblastonm cell lines in vitro
原文传递
导出
摘要 目的探讨13-顺式维甲酸(13-cisRA)体外对3种人神经母细胞瘤(NB)细胞株生长的影响及其作用机制。方法常规培养SH-SY5Y、SK-N-SH和SK-N-BE2细胞株,荧光原位杂交技术(FISH)检测3种细胞MYCN基因扩增情况。不同浓度13-cisRA作用后,采用相差显微镜观察细胞形态变化,酶联免疫吸附法测定细胞培养液神经元特异性烯醇化酶(NSE),细胞增殖毒性检测法检测细胞增殖,流式细胞仪检测细胞凋亡率。结果13-cisRA作用后,3种细胞均伸出多个轴突树突状突起,呈极性化改变,出现细胞分化。FISH检测结果显示,SK-N-BE2细胞为MYCN扩增阳性,13-cisRA作用后MYCN仍扩增阳性,另2种细胞株未见扩增。3种细胞经不同浓度13.cisRA作用后NSE水平随药物作用时间延长而升高,其中SK-N-BE2细胞NSE水平显著升高,差异均有统计学意义(F=27.00,P〈0.0001)。13-cisRA作用48h内均促进细胞增殖,随后转为抑制细胞生长。SH-SY5Y细胞经10μmol/L13-cisfLA作用96h及120h显著增加细胞凋亡(F=16.21,P=0.011;F:16.04,P=0.016);SK-N-SH细胞经1μmol/L及10μmol/L13-cisRA作用48h,细胞惆亡均显著增加(F=15.05,P=0.012;F=31.18,P=0.005);SK-N-BE2细胞经不同浓度13-cisRA(1μmol/L、5μmol/L、10μmol/L)作用120h细胞啊亡均显著增加(F=9.05,P=0.030;F=11.38,P=0.028;F=7.88,P=0.041)。结论13-cisRA体外能显著诱导NB细胞分化,作用48h内促进细胞增殖,随后表现为抑制细胞生长,促进细胞凋亡。13-cisRA对MYCN扩增阳性的细胞在DNA检测水平无改善,提示可能需要联合用药。 Objective To investigate the effects of 13 -eis rctinoie acid (13 -cis RA) in inducing differen- tiation of 3 types of human neuroblastoma (NB) cells in vitro. Methods The status of MYCN gene amplification of cultured SH -SY5Y, SK - N - SH and SK - N - BE2 cells was detected by fluorescence in situ hybridization. After treatment with different concentrations of 13 -cis RA,morphologieal changes were observed by phase -contrast micro= scope, and neuron - specific enolase (NSE) concentrations were determined by enzyme linked immunosorhent assay. The cell viability was measured through cell counting kit -8 assay, and the cell apoptosis was assayed with flow cytome- try (FCM). Results The morphological changes in differentiation were observed in all 3 types of NB ceils after 13 - eis RA treatment. MYCN amplification was detected in SK- N -BE2 cells even after 13 -cis RA treatment,while the other 2 cell lines were amplification -null. After different concentrations of 13 -cis RA treatment, NSE concentration increased with prolonged time, especially for SK - N - BE2 cell( F = 27.00, P 〈 0. 000 1 ). 13 - cis RA stimulated cell proliferation within 48 hours of treatment, and then inhibited cell growth. FCM indicated that the degree of apoptosis in SH - SYSY cell was significantly higher after 13 - cis RA treatment of 10 μmol/L concentration for continuous 96 h and 120 h as compared to the control group (F = 16.21 ,P =0. 011 ;F = 16.04 ,P =0.016). Cell apoptosis of SK - N - SH cell after 13 - cis RA treatment of 1 μmol/L and 10 μmol/L concentration for 48 h,were significantly higher than those of the control group ( F = 15.05, P = 0. 012 ; F = 31.18, P = 0.005 ) ; while SK - N - BE2 cell with different concentra- tions of 13 -cis RA( 1 μmol/L,5 μmoL/L, 10 μmol/L) for 120 h were significantly higher than those of the control group(F=9.05,P=0. 030;F = 11.38,P =0. 028;F =7. 88,P =0. 041). Conclusions The present study showed that 13 - cis RA could induce differentiation of human NB cells in vitro. It induces cell proliferation within 48 hours of 13 - cis RA, and thereafter suppresses cell growth. No improvement was found in MYCN amplification cells with the de- tection of DNA level after 13 -cis RA treatment,which suggests that combined treatment is possibly needed.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2015年第15期1152-1156,共5页 Chinese Journal of Applied Clinical Pediatrics
基金 上海市科学技术委员会科研计划课题(12411952405) 上海市科学技术委员会样本库建设平台(12DZ2295006)
关键词 神经母细胞瘤 诱导分化 13-顺式维甲酸 MYCN基因 Neuroblastoma Differentiation 13 -cis retinoic acid MYCN gene
  • 相关文献

参考文献17

  • 1MolenaarJJ, Domingo-FernándezR, EbusME, et al.LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression[J].Nat Genet, 2012, 44(11):1199-1206.
  • 2StrotherDR, LondonWB, SchmidtML, et al.Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma:results of children's oncology group study P9641[J].J Clin Oncol, 2012, 30(15):1842-1848.
  • 3NuchternJG, LondonWB, BarnewoltCE, et al.A prospective study of expectant observation as primary therapy for neuroblastoma in young infants:a Children's Oncology Group study[J].Ann Surg, 2012, 256(4):573-580.
  • 4徐玲玲,唐雯,李素萍,刘钧澄,梁玉坚,张丽丹,兰洁.婴儿后纵隔神经母细胞瘤1例[J].中华实用儿科临床杂志,2014,29(3):237-238. 被引量:1
  • 5ParkJR, ScottJR, StewartCF, et al.Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma:a Children's Oncology Group study[J].J Clin Oncol, 2011, 29(33):4351-4357.
  • 6马晓莉,金眉,张大伟,王焕民,秦红,秦茂权,王彬,周春菊,曾骐.多学科联合诊治神经母细胞瘤91例临床特征及近期疗效分析[J].中华实用儿科临床杂志,2013,28(3):178-182. 被引量:41
  • 7LiK, DongK, GaoJ, et al.Neuroblastoma management in Chinese children[J].J Invest Surg, 2012, 25(2):86-92.
  • 8CelayJ, BlancoI, LázcozP, et al.Changes in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatment[J].PLoS One, 2013, 8(5):e62771.
  • 9JungGS, LeeKM, ParkJK, et al.Morphogenetic and neuronal characte-rization of human neuroblastoma multicellular spheroids cultured under undifferentiated and all-trans-retinoic acid-differentiated conditions[J].BMB Rep, 2013, 46(5):276-281.
  • 10SonawaneP, ChoHE, TagdeA, et al.Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma[J].Br J Pharmacol, 2014, 171(23):5330-5344.

二级参考文献40

  • 1Fotedar R,Bendjennat M,Fotedar A.Role of the p21WAF1 in the cellular response to UV[J].Cell Cycle,2004 Feb,3(2):134-137
  • 2Bendjennat M,Boulaire J,Jascur T,Brickner H et al.UV irradiation triggers ubiquitin-dependent degradation of p21 (WAF1) to promote DNA repair[J].Cell,2003 Sep,114(5):599-610
  • 3Bunz F,Dutriaux A,Lengauer C,et al.Requirement for p53 and p21 to sustain G2 arrest after DNA damage[J].Science,1998 Nov 20,282(5393):1497-1501
  • 4Iliakis G,Wang Y,Guan J,Wang H.DNA damage checkpoint control in cells exposed to ionizing radiation[ J ].Oncogene,2003Sep1 ,22(37):5834-5847
  • 5Zhou H,Randers-Pehrson P G,Waldern C A et al.Induction of a bystander mutagenic effect of alpha particles in mammalian cells[J].Proc Natl Acad Sci USA,2000 Feb 29,97(5):2099-2104
  • 6Mothersill C,Seymour C.Radiation-induced bystander efforts:past history and future directions[J].Radiat Res,2001 Jun, 155(6):759-767
  • 7Taylor W R,Stark G R.Regulation of the G2/M transition by p53[J].Oncogene,2001 Apr 5 ,20(15):1803-1815
  • 8Chen S,Paul P,Price B D.ATM's leucine-rich domain and adjacent sequences are essential for ATM to regulate the DNA damage response[J].Oncogene,2003 Sep 25,22(41):6332-6339
  • 9Iyer R,Lehnert B E.Effects of ionizing radiation in targeted and nontargeted cells[ J].Arch Biochem Biophys,2000 Apr 1, 376 (1):14-25
  • 10Gandhi V,Ayres M,Halgren R G,Krett N L,Newman R A,Rosen S T.8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells[ J].Cancer Res,2001 July15, 61(14):5474-5479

共引文献43

同被引文献34

  • 1Artene SA, Ciurea ME, Purcaru SO, et al. Biobanking in a constantly developing medical world. ScientificWorldJournal, 2013, 2013: 343275.
  • 2Wagstaff A. International biobanking regulations: the promise and the pitfalls. Cancer World, 2011, 42:23-29.
  • 3Marincola FM. Translational medicine: a two-way road. J Transl Med, 2003, 1(1):1.
  • 4Gao Z, Gu Y, Lv Z, et al. Practical electronic information system andprinted recording promote management accuracy in an early-stage small-scale non-automatic biobank. Biopreserv Biobank, 2015, 13(1): 61-66.
  • 5Dowst H, Pew B, Watkins C, et al. Acquire: an open-source comprehensive cancer biobanking system. Bioinformatics, 2015, 31(10):1655-1662.
  • 6Compton C. Data quality and personalized medicine - the collection, processing and banking of biospecimens. Oncol Exchange, 2014, 13(1):13-15.
  • 7Kang H J, Jeon SY, Park JS, et al. Identification of clinical biomarkers for pre-analytical quality control of blood samples. Biopreserv Biobank, 2013, 11(2):94-100.
  • 8Polasek O. Future of biobanks-bigger, longer, and more dimensional. Croat Med J, 2013, 54(5):496-500.
  • 9Bowton E, Field JR, Wang S, et al. Biobanks and electronic medical records: enabling cost-effective research. Sci Transl Med, 2014, 6(234): 234cm3.
  • 10褚嘉祐,徐玖瑾,傅松滨,林克勤,朱苏玲,黄小琴,陶玉芬,薛雅丽,孙艳阳,杨昭庆,钱亚屏,李璞.中华民族永生细胞库的建立[J].国际遗传学杂志,2008,31(4):241-247. 被引量:13

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部